Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04547062
Status:
COMPLETED
Last Update Posted:
2023-04-28
First Post:
2020-09-04
Brief Title:
Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy Idarubicin and Cytarabine in Patients With Acute Myeloblastic Leukemia AML
Sponsor:
Nantes University Hospital
Organization:
Nantes University Hospital
Organization Data
Organization:
Nantes University Hospital
Class:
OTHER
Study ID:
RC20_0282
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nantes University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None